MPM Oncology Impact Management LP logo

MPM Oncology Impact Management LP Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for MPM Oncology Impact Management LP with $610.9M in long positions as of Q3 2025, 95% allocated to Healthcare, and 49% concentrated in top 10 positions.

Portfolio Value
$610.9M
Top 10 Concentration
49%
Top Sector
Healthcare (95%)
US Exposure
90%
Market Cap Focus
Small Cap
Countries
5

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 94.80%Healthcare
Healthcare
94.80%

Industry Breakdown

2 industries across all sectors

Biotechnology: 92.22%BiotechnologyMedical - Diagnostics & Research: 2.61%
Biotechnology
Healthcare
92.22%
Medical - Diagnostics & Research
Healthcare
2.61%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Large Cap ($10B - $200B): 10.15%Large Cap ($10B - $200B)Mid Cap ($2B - $10B): 27.38%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 52.46%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 5.87%N/A (ETF or Unknown): 4.13%
Large Cap ($10B - $200B)
10.15%
Mid Cap ($2B - $10B)
27.38%
Small Cap ($300M - $2B)
52.46%
Micro Cap ($50M - $300M)
5.87%
N/A (ETF or Unknown)
4.13%

Portfolio Concentration

Top 10 Holdings %
48.78%
Top 20 Holdings %
76.21%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
89.63%
International
10.37%
Countries
5
Largest Int'l Market
Canada - 4.14%
United States of America
89.63% ($547.6M)
34 holdings
Canada
4.14% ($25.3M)
3 holdings
Ireland
2.70% ($16.5M)
1 holdings
Singapore
1.80% ($11.0M)
1 holdings
France
1.73% ($10.5M)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
5.7 quarters
Avg. Top 20
5.3 quarters
Avg. All Positions
4.7 quarters
Median Holding Period
3.5 quarters
Persistence Rate
50.0%
Persistent Holdings Weight
62.28%
Persistent Positions
20
Longest Held
Repare Therapeutics Inc. Common Shares logo
Repare Therapeutics Inc. Common SharesRPTX - 21 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.92%
Avg. Position Weight
2.50%
Largest Position
Madrigal Pharmaceuticals, Inc. Common Stock logo
Madrigal Pharmaceuticals, Inc. Common StockMDGL - 7.54%
Largest Ownership Stake
Context Therapeutics Inc. Common Stock logo
Context Therapeutics Inc. Common StockCNTX - 16.39%
Avg. Ownership Stake
2.40%
Ownership Stake >5%
3
Ownership Stake >1%
20

Historical (Since Q4 2019)

Avg. New Position
4.09%
Avg. Ownership Stake
5.20%
Largest Position
G1 Therapeutics, Inc. Common Stock logo
G1 Therapeutics, Inc. Common StockGTHX - 68.07% (Q4 2019)
Largest Ownership Stake
Context Therapeutics Inc. Common Stock logo
Context Therapeutics Inc. Common StockCNTX - 19.61% (Q4 2024)

Portfolio Turnover

Current Quarter

Turnover Ratio
13.9%
Value Traded
$84.85M
Positions Added
7
Positions Exited
11

Historical (Since Q4 2019)

Avg. Turnover Ratio
17.6%
Avg. Positions Added
5
Avg. Positions Exited
4
Highest Turnover
50.0%
Q4 2019

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.